JP2006524206A5 - - Google Patents

Download PDF

Info

Publication number
JP2006524206A5
JP2006524206A5 JP2006505223A JP2006505223A JP2006524206A5 JP 2006524206 A5 JP2006524206 A5 JP 2006524206A5 JP 2006505223 A JP2006505223 A JP 2006505223A JP 2006505223 A JP2006505223 A JP 2006505223A JP 2006524206 A5 JP2006524206 A5 JP 2006524206A5
Authority
JP
Japan
Prior art keywords
methyl
propyl
ethyl
dioxide
indole
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
JP2006505223A
Other languages
English (en)
Japanese (ja)
Other versions
JP2006524206A (ja
Filing date
Publication date
Priority claimed from GBGB0309221.0A external-priority patent/GB0309221D0/en
Application filed filed Critical
Publication of JP2006524206A publication Critical patent/JP2006524206A/ja
Publication of JP2006524206A5 publication Critical patent/JP2006524206A5/ja
Withdrawn legal-status Critical Current

Links

JP2006505223A 2003-04-23 2004-04-21 三環式インドール誘導体およびアルツハイマー病治療におけるそれらの使用法 Withdrawn JP2006524206A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0309221.0A GB0309221D0 (en) 2003-04-23 2003-04-23 Novel compounds
PCT/EP2004/004244 WO2004094430A1 (en) 2003-04-23 2004-04-21 Tricyclic indole derivatives and their use in the treatment of alzheimer’s disease

Publications (2)

Publication Number Publication Date
JP2006524206A JP2006524206A (ja) 2006-10-26
JP2006524206A5 true JP2006524206A5 (enExample) 2007-05-10

Family

ID=9957152

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2006505223A Withdrawn JP2006524206A (ja) 2003-04-23 2004-04-21 三環式インドール誘導体およびアルツハイマー病治療におけるそれらの使用法

Country Status (16)

Country Link
US (1) US20060229302A1 (enExample)
EP (1) EP1620438A1 (enExample)
JP (1) JP2006524206A (enExample)
KR (1) KR20050111797A (enExample)
CN (1) CN1809573A (enExample)
BR (1) BRPI0409622A (enExample)
CA (1) CA2523291A1 (enExample)
CO (1) CO5700829A2 (enExample)
GB (1) GB0309221D0 (enExample)
IS (1) IS8135A (enExample)
MA (1) MA27674A1 (enExample)
MX (1) MXPA05011365A (enExample)
NO (1) NO20055442L (enExample)
RU (1) RU2005136370A (enExample)
WO (1) WO2004094430A1 (enExample)
ZA (1) ZA200508041B (enExample)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PE20040762A1 (es) * 2002-11-27 2004-11-06 Elan Pharm Inc Ureas substituidas y carbamatos utiles para el tratamiento de la enfermedad de alzheimer
GB0328900D0 (en) * 2003-12-12 2004-01-14 Glaxo Group Ltd Novel compounds
US7763609B2 (en) 2003-12-15 2010-07-27 Schering Corporation Heterocyclic aspartyl protease inhibitors
GB0411404D0 (en) * 2004-05-21 2004-06-23 Glaxo Group Ltd Novel compounds
BRPI0515383A (pt) * 2004-09-21 2008-07-22 Pfizer Prod Inc n-etil hidroxietilamina útil no tratamento de condições do snc
GB0422765D0 (en) * 2004-10-13 2004-11-17 Glaxo Group Ltd Novel compounds
GB0422755D0 (en) * 2004-10-13 2004-11-17 Glaxo Group Ltd Novel compounds
GB0422766D0 (en) * 2004-10-13 2004-11-17 Glaxo Group Ltd Novel compounds
WO2006088705A1 (en) * 2005-02-14 2006-08-24 Wyeth Terphenyl guanidines as [beta symbol] -secretase inhibitors
GB0506562D0 (en) * 2005-03-31 2005-05-04 Glaxo Group Ltd Novel compounds
MX2007012341A (es) 2005-04-08 2008-02-12 Comentis Inc Compuestos que inhiben actividad beta-secretasa y metodos de uso de los mismos.
WO2007019078A2 (en) * 2005-08-03 2007-02-15 Merck & Co., Inc. Tricyclic beta-secretase inhibitors for the treatment of alzheimer's disease
US7838676B2 (en) * 2005-11-21 2010-11-23 Amgen Inc. Beta-secretase modulators and methods of use
US7872009B2 (en) * 2005-11-21 2011-01-18 Amgen Inc. Beta-Secretase modulators and methods of use
EP1971598A1 (en) * 2005-11-21 2008-09-24 Amgen Inc. Beta-secretase modulators and methods of use
US7745484B2 (en) 2005-11-21 2010-06-29 Amgen Inc. Beta-secretase modulators and methods of use
CA2687608C (en) 2007-05-25 2013-07-02 Amgen Inc. Substituted hydroxyethyl amine compounds as beta-secretase modulators and methods of use
CL2008001500A1 (es) 2007-05-25 2008-12-26 Amgen Inc Compuestos derivados de hidroxietil amina sustituidas, moduladores de betasecretasa; proceso de preparacion de dichos c ompuestos; composicion farmaceutica que los comprende; y su uso para tratar un trastorno neurologico, tal como alzheimer, sindrome de down, demencia degenerativa, entre otros.
FR2919288B1 (fr) * 2007-07-27 2009-09-04 Sanofi Aventis Sa Derives de 1,2,3,4-tetrahydropyrrolo[1,2-a]pyrazine-6- carboxamides, leur preparation et leur application en therapeutique.
FR2919285B1 (fr) 2007-07-27 2012-08-31 Sanofi Aventis Derives de 1-oxo-isoindoline-4-carboxamides et de 1-oxo- 1,2,3,4-tetrahydroisoquinoleine-5-carboxamides, leur preparation et leur application en therapeutique.
KR20100050485A (ko) * 2007-07-27 2010-05-13 사노피-아벤티스 1,2,3,4-테트라히드로피롤로[1,2-a]피라진-6-카르복스아미드 및 2,3,4,5-테트라히드로피롤로[1,2-a][1,4]-디아제핀-7-카르복스아미드 유도체, 그의 제조 및 치료적 용도
FR2919286A1 (fr) 2007-07-27 2009-01-30 Sanofi Aventis Sa Derives de derives de 1-oxo-1,2-dihydroisoquinoleine-5- carboxamides et de 4-oxo-3,4-dihydroquinazoline-8- carboxamides,leur preparation et leur application en therapeutique.
FR2919289B1 (fr) * 2007-07-27 2009-09-04 Sanofi Aventis Sa Derives de 2,3,4,5-tetrahydropyrrolo[1,2-a][1,4]- diazepine-7-carboxamides, leur preparation et leur application en therapeutique.
WO2013148130A1 (en) * 2012-03-29 2013-10-03 Oklahoma Medical Research Foundation Inhibition of memapsin 1 cleavage in the treatment of diabetes
RU2764243C2 (ru) * 2017-09-22 2022-01-14 ДЖУБИЛАНТ ЭПИПЭД ЭлЭлСи Гетероциклические соединения в качестве ингибиторов PAD
WO2019075358A1 (en) * 2017-10-13 2019-04-18 Ghosh Arun K BACE1 INHIBITORS FOR THE TREATMENT OF ALZHEIMER'S DISEASE
US12043631B2 (en) 2017-10-13 2024-07-23 Purdue Research Foundation BACE1 inhibitors for the treatment of Alzheimer's disease

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1998033795A1 (en) * 1997-02-04 1998-08-06 The Regents Of The University Of California Nanomolar, non-peptide inhibitors of cathepsin d
US6207664B1 (en) * 1998-11-25 2001-03-27 Pfizer Inc. Squalene synthetase inhibitor agents
CA2410680A1 (en) * 2000-06-30 2002-01-10 Elan Pharmaceuticals, Inc. Compounds to treat alzheimer's disease

Similar Documents

Publication Publication Date Title
RU2005136370A (ru) Трициклические индоловые производные и их применение в лечении болезни альцгеймера
JP7278359B2 (ja) Shp2の活性を阻害するための化合物および組成物
JP6738933B2 (ja) Rbポジティブ異常細胞増殖に対するhspc温存治療
JP2014511893A5 (enExample)
JP2018521017A5 (enExample)
KR20190041471A (ko) 케모카인 수용체 조절제 및 이의 용도
KR20170117578A (ko) 플루오르화 테트라히드로나프티리디닐 노난산 유도체 및 이의 용도
JP2014526501A5 (enExample)
JP2006510716A5 (enExample)
JP2011527683A5 (enExample)
JP2015519368A5 (enExample)
JP2018531987A5 (enExample)
JP2019510752A (ja) オートタキシン阻害剤の組成物及び合剤
CN108430475B (zh) 用于治疗慢性咳嗽的奥维匹坦
JP2018515563A (ja) 化合物
JP2013520420A5 (enExample)
JP2017525721A (ja) 認知欠損または認知障害に伴って進行する神経障害のおよび神経変性疾患の処置および予防のための製品
JP2007513913A5 (enExample)
JP2015508092A5 (enExample)
RU2006124863A (ru) Трициклические производные индолгидроксиэтиламина и их применение при лечении болезни альцгеймера
JP2016508135A5 (enExample)
JP2026040489A (ja) 骨髄増殖性新生物の治療のためのリシン特異的ヒストンデメチラーゼ阻害剤
JP2023525359A5 (enExample)
JP2024535596A (ja) ヒト免疫不全ウイルス複製の阻害薬
JP2024517789A5 (enExample)